Lifestyle modifications for the prevention and treatment of cardiovascular disease: an evidence-based approach
- PMID: 15311577
Lifestyle modifications for the prevention and treatment of cardiovascular disease: an evidence-based approach
Abstract
Two conditions contributing to cardiovascular disease (CVD) are hypertension and diabetes mellitus. Multiple metabolic components contribute to hypertension. These same metabolic and hemodynamic abnormalities play a vital role in type 2 diabetes mellitus, which is often accompanied by the metabolic syndrome. Metabolic syndrome includes elevated blood pressure, increased triglycerides, decreased high-density lipoprotein (HDL)-cholesterol, and central obesity. Additional features are the prothrombotic state, endothelial dysfunction, and markers for inflammation. Insulin resistance is central to the metabolic syndrome. Through a meta-analysis of multiple studies, an assessment of various life-style modifications to reduce CVD is discussed with recommendations on their validity and value.
Similar articles
-
Management issues in the metabolic syndrome.J Assoc Physicians India. 2006 Oct;54:797-810. J Assoc Physicians India. 2006. PMID: 17214277 Review.
-
Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.Am J Cardiol. 2007 Feb 19;99(4A):68B-79B. doi: 10.1016/j.amjcard.2006.11.007. Epub 2006 Dec 27. Am J Cardiol. 2007. PMID: 17307059 Review.
-
Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.J Am Acad Nurse Pract. 2005 Dec;17(12):535-41. doi: 10.1111/j.1745-7599.2005.00083.x. J Am Acad Nurse Pract. 2005. PMID: 16293162
-
Lifestyle modification and endothelial function in obese subjects.Expert Rev Cardiovasc Ther. 2005 Mar;3(2):231-41. doi: 10.1586/14779072.3.2.231. Expert Rev Cardiovasc Ther. 2005. PMID: 15853597 Review.
-
Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.Diabetes Obes Metab. 2006 May;8(3):237-49. doi: 10.1111/j.1463-1326.2005.00521.x. Diabetes Obes Metab. 2006. PMID: 16634983 Review.
Cited by
-
Expanded network of inflammatory markers of atherogenesis: where are we now?Open Cardiovasc Med J. 2010 Feb 23;4:38-44. doi: 10.2174/1874192401004020038. Open Cardiovasc Med J. 2010. PMID: 20305745 Free PMC article.